Expression of beta-dystroglycan is lost in squamous cell and adenocarcinomas of the oesophagus and this loss is significantly related to increasing tumour stage

Expression of beta-dystroglycan is lost in squamous cell and adenocarcinomas of the oesophagus and this loss is significantly related to increasing tumour stage

Bibliographic Details
Main Authors:	Parbery-Clark, C, Lippitt, J, Bury, J, Ackroyd, R, Stoddard, C, Wyman, A, Harrison, R, Hamdy, F, Winder, S, Cross, S
Format:	Conference item
Published:	2005

Similar Items

Loss of intercellular expression of beta-dystroglycan is a common event in prostate cancer and is significantly associated with loss of differentiation
by: Cross, S, et al.
Published: (2005)

There is loss of expression of S100A8 and S100A9 in oesophageal squamous carcinoma
by: Clarke, L, et al.
Published: (2005)

Dystroglycan function is a novel determinant of tumor growth and behavior in prostate cancer.
by: Mitchell, A, et al.
Published: (2013)

Barrett's oesophagus and adenocarcinoma
by: Lao-Sirieix Pierre, et al.
Published: (2004-05-01)

Expression of S100A2, S100A4, S100A6 and S100A7 in oesophageal cancers follows the pattern of expression in the tissues from which they are derived and does not show any significant association with any other clinicopathological parameters
by: Clarke, L, et al.
Published: (2005)

Tissue microarray immunohistochemistry for S100A2, S100A4, S100A6, S100A8, S100A9, S100B and annexin I with unsupervised cluster analysis produces a useful classification of oesophageal cancers
by: Clarke, L, et al.
Published: (2005)

Barrett's oesophagus and oesophageal adenocarcinoma
by: Bird-Lieberman, E, et al.
Published: (2011)

THE CLONAL PROGRESSION OF BARRETT'S OESOPHAGUS TO OESOPHAGEAL ADENOCARCINOMA
by: Khan, S, et al.
Published: (2012)

Epidemiology of Barrett’s oesophagus and oesophageal adenocarcinoma
by: Nancy Perez, et al.
Published: (2019-03-01)

Dystroglycan versatility in cell adhesion: a tale of multiple motifs
by: Winder Steve J, et al.
Published: (2010-02-01)

The Role of β-Dystroglycan in Nuclear Dynamics
by: Matthew Cook, et al.
Published: (2024-02-01)

A rare case of bipartite combined tumour of the oesophagus
by: Nicholette Goh, et al.
Published: (2019-05-01)

Dystroglycan, Tks5 and Src mediated assembly of podosomes in myoblasts.
by: Oliver Thompson, et al.
Published: (2008-01-01)

Abrikossoff’s Tumour of OesophagusAn Innocent Bystander or a Silent Killer?
by: Kuppusamy Senthamizhselvan, et al.
Published: (2020-10-01)

Germline variation in inflammation-related pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma
by: Buas, M, et al.
Published: (2016)

Pyopericardium secondary to achalasia-associated squamous cell carcinoma of the oesophagus
by: Mason, J, et al.
Published: (2016)

Co-Existence Of Pemphigus Foliaceous And Squamous Cell Carcinoma Of Oesophagus
by: Rani mittal Radha, et al.
Published: (1998-01-01)

Endoscopic Management of Dysplastic Barrett’s Oesophagus and Early Oesophageal Adenocarcinoma
by: Leonardo Henry Eusebi, et al.
Published: (2023-09-01)

Malignant peripheral nerve sheath tumour of the oesophagus: a case report
by: Kento Tomizawa, et al.
Published: (2020-07-01)

Increased detection rates of Barrett's oesophagus without rise in incidence of oesophageal adenocarcinoma
by: D Hurschler, et al.
Published: (2003-09-01)

A Comparative Study of α-Dystroglycan Glycosylation in Dystroglycanopathies Suggests that the Hypoglycosylation of α-Dystroglycan Does Not Consistently Correlate with Clinical Severity
by: Jimenez-Mallebrera, C, et al.
Published: (2009)

Prognostic, Diagnostic and Predictive Biomarkers in the Barrett’s Oesophagus-Adenocarcinoma Disease Sequence
by: Darragh O’Dowd, et al.
Published: (2022-07-01)

Dystroglycan Depletion Impairs Actin-Dependent Functions of Differentiated Kasumi-1 Cells.
by: Marco Antonio Escárcega-Tame, et al.
Published: (2015-01-01)

Prediction of a positive circumferential resection margin at surgery following neoadjuvant chemotherapy for adenocarcinoma of the oesophagus
by: W. R. C. Knight, et al.
Published: (2019-12-01)

Brain involvement in muscular dystrophies with defective dystroglycan glycosylation
by: Clement, E, et al.
Published: (2008)

N-terminal domain on dystroglycan enables LARGE1 to extend matriglycan on α-dystroglycan and prevents muscular dystrophy
by: Hidehiko Okuma, et al.
Published: (2023-02-01)

Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis.
by: Gharahkhani, P, et al.
Published: (2016)

Plectin 1f scaffolding at the sarcolemma of dystrophic (mdx) muscle fibers through multiple interactions with beta-dystroglycan.
by: Rezniczek, G, et al.
Published: (2007)

Unusual foreign bodies in the oesophagus
by: W. F.C. van Gelderen, et al.
Published: (1997-06-01)

The Molecular Basis and Biologic Significance of the β-Dystroglycan-Emerin Interaction
by: Wendy Lilián Gómez-Monsivais, et al.
Published: (2020-08-01)

Prognostic significance of cyclooxygenase-2 (COX-2) expression in patients with surgically resectable adenocarcinoma of the oesophagus
by: Cree Ian A, et al.
Published: (2006-05-01)

Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).
by: González, C, et al.
Published: (2006)

Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST)
by: González, C, et al.
Published: (2006)

Decellularisation Of porcine oesophagus
by: Ong, Zhen Yang
Published: (2019)

Decellularisation of porcine oesophagus
by: Lim, Kenneth Jun Yang
Published: (2019)

Update on Barrett’s Oesophagus
by: Claudia Tarlarini, et al.
Published: (2014-12-01)

Giant Leiomyoma of the Oesophagus
by: Dhamodaran Kandasamy, et al.
Published: (2017-04-01)

BARRETT’S OESOPHAGUS IN 2016
by: Monjur Ahmed
Published: (2016-12-01)

Cancer of the oesophagus in achalasia
by: S Maeyaert, et al.
Published: (2013-01-01)

Endoscopic radiofrequency ablation for squamous dysplasia of the oesophagus: Interventional procedures guidance [IPG497]
by: National Institute for Health and Care Excellence, CA, et al.
Published: (2014)